Interestingly, it has also been reported that the administration of bile acids inhibits the TLR4-NF-κB signaling pathway, and thereby reduces inflammation and insulin resistance (Chen et al., 2019; Xing et al., 2020; Liu et al., 2022). The gene discussed is NFKB1; the disease is Insulin resistance.